Sunshine Biopharma, Inc Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sunshine Biopharma, Inc quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Sunshine Biopharma, Inc Depreciation for the quarter ending June 30, 2024 was $50.9K, a 45.9% increase year-over-year.
  • Sunshine Biopharma, Inc annual Depreciation for 2023 was $111K, a 436% increase from 2022.
  • Sunshine Biopharma, Inc annual Depreciation for 2022 was $20.6K, a 62% increase from 2021.
  • Sunshine Biopharma, Inc annual Depreciation for 2021 was $12.7K, a 9.42% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $111K +$90.1K +436% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $20.6K +$7.9K +62% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $12.7K -$1.33K -9.42% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-21
2020 $14.1K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2016 $1.81K +$1.33K +278% Jan 1, 2016 Dec 31, 2016 10-K 2017-04-17
2015 $479 +$479 Jan 1, 2015 Dec 31, 2015 10-K 2017-04-17
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.